Canadian Health Industry News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Canadian Health Industry News.

Press releases published on September 24, 2026

Sep. 24, 2026

Naqi Logix Wins 2026 TWICE VIP Award for Third Consecutive Year

Indeterminate EIN Presswire

Sep. 24, 2026

CMTA Invests $110,500 to Develop Novel ASO Medicine for CMT2A

Indeterminate EIN Presswire

Sep. 24, 2026

TCE Group Advances AI Medical Transcription for Rapid Clinical Documentation

Indeterminate EIN Presswire

Sep. 24, 2026

York U receives nearly $10 million from Wellcome to continue the fight against antimicrobial resistance

Indeterminate GlobeNewswire

Sep. 24, 2026

The True Cost of Prohibition: Lost Tax Revenue, Unsafe Products, and a Booming Illicit Vape Trade

Indeterminate GlobeNewswire

Sep. 24, 2026

PROLLENIUM® Spotlights the Future of Regenerative Aesthetics at Aesthetic Next 8.0 and Chateau Prollenium Dallas

Indeterminate GlobeNewswire

Sep. 24, 2026

Integrating Early CMC into Drug Discovery and Candidate Selection: Lessons from WuXi AppTec

Indeterminate EIN Presswire

Sep. 24, 2026

MADD Canada Policy Symposium Brings Experts Together to Advance Solutions to Prevent Impaired Driving

Indeterminate GlobeNewswire

Sep. 24, 2026

Le symposium de MADD Canada rassemble des experts pour trouver des solutions pour prévenir la conduite avec capacités affaiblies

Indeterminate GlobeNewswire

Sep. 24, 2026

Inagene launches GLP-1 Insights Program combining genetic insights with registered dietitian support to help Canadians understand their genetic response to weight management and diabetes medications

Indeterminate GlobeNewswire

Sep. 24, 2026

Cronos Hosts 2026 Investor Day

Indeterminate GlobeNewswire

Sep. 24, 2026

Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR

Indeterminate GlobeNewswire

Sep. 24, 2026

Medicenna Announces Oral Presentation of New Bizaxofusp Results in Recurrent Glioblastoma at the 2026 Society for Neuro-Oncology Annual Meeting

Indeterminate GlobeNewswire